Clinical evaluation and microbiology of oropharyngeal infection due to fluconazole-resistant Candida in human immunodeficiency virus - Infected patients

Clinical Infectious Diseases

Volumn 26, Issue 4, 1998, Pages 960-963

  Revankar, Sanjay G ^a   Dib, Olga P ^b   Kirkpatrick, William R ^b   McAtee, Robert K ^b   Fothergill, Annette W ^b   Rinaldi, Michael G ^b   Redding, Spencer W ^b   Patterson, Thomas F ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE;

ANTIBIOTIC RESISTANCE; ARTICLE; CANDIDA; CANDIDIASIS; DOSE RESPONSE; DRUG RESPONSE; FUNGUS CULTURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; ORAL DRUG ADMINISTRATION; OROPHARYNX; PHARYNGITIS; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0031916096     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/513950     Document Type: Article

References (19)

1. De Wit S, Weerts D, Goossens H, Clumeck N. Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS. Lancet 1989;1:746-7.
2. Koletar SL, Russell JA, Fass RJ, Plouffe JF. Comparison of oral fluconazole and clotrimazole troches as treatment for oral candidiasis in patients infected with human immunodeficiency virus. Antimicrob Agents Chemother 1990;34:2267-8.
3. Just-Nubling G, Gentschew G, Meibner K, et al. Fluconazole prophylaxis of recurrent oral candidiasis in HIV-positive patients. Eur J Clin Microbiol Infect Dis 1991;10:917-21.
4. Rex JH, Pfaller MA, Barry AL, Nelson PW, Webb CW. Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. Antimicrob Agents Chemother 1995;39:40-4.
5. Law D, Moore CB, Wardle HM, Ganguli LA, Keaney MGL, Denning DW. High prevalence of antifungal resistance in Candida spp. from patients with AIDS. J Antimicrob Chemother 1994;34:659-68.
6. Maenza JR, Keruly JC, Moore RD, Chaisson RE, Merz WG, Gallant JE. Risk factors for fluconazole-resistant candidiasis in human immunodeficiency virus-infected patients. J Infect Dis 1996;173:219-25.
7. Powderly WG. Resistant candidiasis. AIDS Res Hum Retroviruses 1994;10:925-9.
8. Fan-Havard P, Capano D, Smith SM, Mangia A, Eng RH. Development of resistance in Candida isolates from patients receiving prolonged antifungal therapy. Antimicrob Agents Chemother 1991;35:2302-5.
9. Redding S, Smith J, Farinacci G, et al. Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis. Clin Infect Dis 1994;18:240-2.
10. Revankar SR, Kirkpatrick WR, McAtee RK, et al. Detection and significance of fluconazole resistance in oropharyngeal candidiasis in human immunodeficiency virus-infected patients. J Infect Dis 1996;174:821-7.
11. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts: approved standard. NCCLS document M27-A. Wayne, Pennsylvania: National Committee for Clinical Laboratory Standards, 1997.
12. Patterson TF, Revankar SR, Kirkpatrick WR, et al. Simple method for detecting fluconazole-resistant yeasts with chromogenic agar. J Clin Microbiol 1996;34:1794-7.
13. Millon L, Manteaux A, Reboux G, et al. Fluconazole-resistant recurrent oral candidiasis in human immunodeficiency virus-positive patients: persistence of Candida albicans strains with the same genotype. J Clin Microbiol 1994;32:1115-8.
14. Maenza JR, Merz WG, Romagnoli MJ, Keruly JC, Moore RD, Gallant JE. Infection due to fluconazole-resistant Candida in patients with AIDS: prevalence and microbiology. Clin Infect Dis 1997;24:28-34.
15. Sanguineti A, Carmichael JK, Campbell K. Fluconazole-resistant Candida albicans after long-term suppressive therapy. Arch Intern Med 1993;153:1122-4.
16. Sangeorzan JA, Bradley SF, He X, et al. Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance. Am J Med 1994;97:339-46.
17. Thoma-Greber E, Korting HC, Bogner J, Goebel FD. Fluconazole-resistant oral candidosis in a repeatedly treated female AIDS patient. Mycoses 1994;37:35-8.
18. Rex JH, Pfaller MA, Galgiani JN, et al. Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and Candida infections. Clin Infect Dis 1997;24:235-47.
19. Barchiesi F, Colombo AL, McGough DA, Fothergill AW, Rinaldi MG. In vitro activity of itraconazole against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus. Antimicrob Agents Chemother 1994;38:1530-3.